Research
We are driving the next generation of discoveries to address critical cancer challenges and accelerate the translation of scientific evidence into patient benefit.
Education
Fostering an outstanding cancer care workforce to help maintain and enhance world-leading patient outcomes through online learning, courses and events.
Equity
Pursuing equity in access to cancer care and outcomes for all Victorians affected by cancer.
About us
Research, academic and clinical institutions working together to accelerate cancer research, knowledge and expertise to benefit all.
News & Events
The VCCC Alliance brings you the latest in cancer research, education and clinical care through engaging, relevant and informative events.

Chief Executive Message, October 2024

Read the latest update from the VCCC Alliance Chief Executive, Professor Grant McArthur AO.
03 Oct 2024

Workforce and data key elements of new Victorian Cancer Plan 

In early September we welcomed the state government’s Victorian Cancer Plan 2024-2028, and acknowledged the strong alignment with our own five-year strategy.

In particular, we strongly support the initiatives around building the workforce capabilities of the cancer sector, and system design and delivery driven by research, data and intelligence. The importance of the continuing education of our cancer workers, and innovation driven by data and intelligence, cannot be overstated.

We look forward to continuing to work alongside the Victorian government and the cancer sector to deliver the Victorian Cancer Plan 2024-2028. Many thanks to our Board Chair, Professor Sanchia Aranda AM, for attending the launch of the plan. Read more about the Victorian Cancer Plan and the VCCC Alliance strategy here.

Sanchia Mary Anne Thomas VCP

Professor Sanchia Aranda AM with Minister for Health, the Hon Mary-Anne Thomas MP at the launch of the Victorian Cancer Plan

Driving best cancer outcomes for all

One of the key principles of the Victorian Cancer Plan is that Every Victorian can expect equity of access and outcomes. We’re excited about the VCCC Alliance equity programs, funded in the 2024-25 Victorian State Budget, getting underway. These programs will improve the equitable delivery of cancer care – including to culturally diverse and Aboriginal and Torres Strait Islander communities – and palliative care for those affected by cancer in regional Victoria. In this edition of Alliance, we’ll introduce you to Care Plus Extend, the palliative care project.

Reflections from ESMO

The European Society for Medical Oncology’s annual event, held in Barcelona this year, was inspiring as always and it was brilliant to see some of our members in attendance and presenting.

It was exciting to hear that novel therapeutics continue to develop at pace and scale, with cell therapies, sophisticated protein engineering and advances in small molecule chemistry – including protein degraders that offer the potential to inhibit ‘undruggable targets’ – up for discussion. Here are a few notable presentations:

  • Dr James Whittle from the Brain Cancer Centre at our member organisation WEHI, presenting on glioma. Click here to access the abstract.
  • De-escalation and de-intensification of treatment remains an area of focus - Congratulations to Professor Trevor Leong and the Australasian Gastro-Intestinal Trials Group on the TOPGEAR trial, looking at preoperative chemoradiotherapy for resectable gastric cancers. Read the study in the New England Journal of Medicine here
  • I really enjoyed the new presidential symposium Eyes to the future, which featured personalised medicine and tumour agnostic treatments (the ROME trial), AI revolution being led by computational pathology, total neoadjuvant therapy in rectal cancer and the NO-CUT trial, precision oncology in immunotherapy of lung cancer, and the emerging opportunities of therapy targeting the epigenome, discussed by Cigall Kadoch. Details on this session are here.
Announcing our Research and Education Leads

Congratulations to our new Research and Education Leads who have been announced in this edition of Alliance. We’re proud of the leadership we continue to show in the areas of primary care, cancer nursing, Aboriginal and Torres Strait Islander health, Lung cancer and lung cancer screening, and regional and rural health.

Congratulations

Warmest congratulations to our long-term leader, Dr Dishan Herath on his appointment as Peter Mac’s next Chief Medical Officer. Dr Herath currently chairs the VCCC Alliance Cancer Research Advisory Committee, is Acting Executive Director, Digital Healthcare Innovation at Peter Mac, Head of Cancer Services at Western Health and Clinical Director of the Western and Central Melbourne Integrated Cancer Services (WCMICS). He was formerly Chief Medical Information Officer (CMIO) at Peter Mac and has been instrumental in the introduction and continual adaptation of the Epic Electronic Medical Record across Parkville Precinct health services. We wish him all the best in his new role.   

I was also delighted to see three NHMRC Synergy Grants for cancer - amazingly out of 10 total nationally - awarded, featuring multiple Alliance members tackling microbiome, T-cell immunology and immunotherapy (CIA Shaneen Sandhu with investigators from WEHI, Doherty Institute and Peter Mac),  mechanism of immune evasion in cancer (CIA Marie-Liesse Asselin-Labat with investigators from, Doherty Institute, WEHI and ONJCRI/Peter Mac) and targeting RAS and BRAF in colorectal cancer (CIA John Mariadason with investigators from WEHI, ONJCRI and Peter Mac). 

Congratulations to all - this is a clear illustration of strengths in cancer immunology and therapeutics across the Alliance, and is truly collaboration in action!

Prof Grant McArthur AO
Chief Executive Officer

Get the latest in cancer news, events and more, direct to your inbox

Join a network of Victorian cancer researchers, clinicians and consumers to keep your finger on the pulse.